US FDA plans external expert network for emerging technologies
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has set in motion plans to create a network of external scientific experts that its devices unit can use to gain faster access to specialised knowledge about emerging technologies and other topics.